CEO INTERVIEW: Breaking the Brain Barrier: CNS Pharma's Quest to Revolutionize Cancer Treatment

In this inspiring and revelatory episode Carmel Fisher chats with NASDAQ-listed $CNSP (CNS Pharmaceuticals) CEO John Climaco about their innovative approach to treating brain cancer by modifying existing drugs to cross the blood-brain barrier, potentially offering new hope for glioblastoma patients with limited treatment options.Read Article...https://www.harvestcomms.com/news/cns-pharmaceuticals%3A-pioneering-brain-cancer-treatmentDisclaimer:The Harvest podcast is for informational and educational purposes only. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company or institution mentioned.The content of this podcast does not constitute investment, legal, or tax advice. Any strategies or investment ideas discussed may not be suitable for all investors. Listeners should conduct their own research and consult with professional advisors before making any investment decisions.Past performance is not indicative of future results. The host, guests, and producers of this podcast may hold positions in the securities discussed. This podcast may contain forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those projected in these forward-looking statements.Investing in securities involves risk, including the potential loss of principal. Please be aware that the stock market can be volatile and investment values can fluctuate.By listening to this podcast, you agree to not hold the host, guests, producers, or any affiliated companies liable for any investment decisions you make.Always do your own due diligence and invest responsibly.